0

    524790

    EVERESTO

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    EVEREST ORGANICS LTD. Share Price Today

    Investment Returns

    Over 1 Month 27.98% Over 3 Months 33.50% Over 6 Months -24.51% Over 1 Year -0.01%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    EVEREST ORGANICS LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 332.10
    • P/E Ratio (TTM) 59.34
    • Beta 0.81
    • Book Value / share 79.69
    • Return on equity -2.23%
    • EPS (TTM) 5.56
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 2.63
    info icon alternate text

    EVEREST ORGANICS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 48.75
    Operating Expense 46.73
    Net Profit 2.63
    Net Profit Margin (%) 5.39
    Earnings Per Share (EPS) 2.69
    EBITDA 6.85
    Effective Tax Rate (%) -21.19
    Particulars DEC 2025 (Values in Cr)
    Revenue 42.59
    Operating Expense 41.80
    Net Profit 0.36
    Net Profit Margin (%) 0.84
    Earnings Per Share (EPS) 0.37
    EBITDA 3.79
    Effective Tax Rate (%) 65.38
    Particulars SEP 2025 (Values in Cr)
    Revenue 51.00
    Operating Expense 48.62
    Net Profit 1.16
    Net Profit Margin (%) 2.27
    Earnings Per Share (EPS) 1.19
    EBITDA 5.42
    Effective Tax Rate (%) 56.92
    Particulars JUN 2025 (Values in Cr)
    Revenue 53.81
    Operating Expense 52.20
    Net Profit 1.41
    Net Profit Margin (%) 2.62
    Earnings Per Share (EPS) 1.45
    EBITDA 4.99
    Effective Tax Rate (%) 35.18
    Particulars MAR 2025 (Values in Cr)
    Revenue 40.93
    Operating Expense 40.21
    Net Profit 2.91
    Net Profit Margin (%) 7.10
    Earnings Per Share (EPS) 2.30
    EBITDA 3.65
    Effective Tax Rate (%) -206.31
    Particulars MAR 2026 (Values in Cr)
    Revenue 196.16
    Operating Expense 189.36
    Net Profit 5.55
    Net Profit Margin (%) 2.82
    Earnings Per Share (EPS) 5.70
    EBITDA 21.06
    Effective Tax Rate (%) 31.05
    Particulars MAR 2025 (Values in Cr)
    Revenue 159.48
    Operating Expense 163.41
    Net Profit -1.29
    Net Profit Margin (%) -0.80
    Earnings Per Share (EPS) -1.33
    EBITDA 7.91
    Effective Tax Rate (%) 60.18
    Particulars MAR 2024 (Values in Cr)
    Revenue 197.24
    Operating Expense 197.52
    Net Profit 0.14
    Net Profit Margin (%) 0.07
    Earnings Per Share (EPS) 0.17
    EBITDA 11.87
    Effective Tax Rate (%) 77.04
    Particulars MAR 2023 (Values in Cr)
    Revenue 183.05
    Operating Expense 189.90
    Net Profit -0.18
    Net Profit Margin (%) -0.09
    Earnings Per Share (EPS) -0.23
    EBITDA 7.86
    Effective Tax Rate (%) 300.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 200.05
    Operating Expense 200.51
    Net Profit 1.14
    Net Profit Margin (%) 0.56
    Earnings Per Share (EPS) 1.43
    EBITDA 8.64
    Effective Tax Rate (%) 34.48
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 71.00
    ROE % -2.23
    ROCE % 1.72
    Total Debt to Total Equity 0.91
    EBITDA Margin 4.34
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 57.30
    ROE % 0.30
    ROCE % 5.94
    Total Debt to Total Equity 1.18
    EBITDA Margin 5.25
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 57.77
    ROE % -0.17
    ROCE % 3.55
    Total Debt to Total Equity 0.97
    EBITDA Margin 3.75
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 58.50
    ROE % 2.44
    ROCE % 6.02
    Total Debt to Total Equity 0.66
    EBITDA Margin 3.75
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 58.22
    ROE % 33.97
    ROCE % 32.07
    Total Debt to Total Equity 0.51
    EBITDA Margin 11.53
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 6.63
    Total Assets 224.48
    Total Liabilities 224.48
    Total Equity 69.94
    Share Outstanding 0
    Price to Book Ratio 3.55
    Return on Assets (%) -0.57
    Return on Capital (%) -1.1
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.82
    Total Assets 226.72
    Total Liabilities 226.72
    Total Equity 45.83
    Share Outstanding 0
    Price to Book Ratio 2.00
    Return on Assets (%) 0.06
    Return on Capital (%) 0.13
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.82
    Total Assets 201.84
    Total Liabilities 201.84
    Total Equity 46.21
    Share Outstanding 0
    Price to Book Ratio 1.65
    Return on Assets (%) -0.09
    Return on Capital (%) -0.19
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.65
    Total Assets 177.99
    Total Liabilities 177.99
    Total Equity 46.79
    Share Outstanding 0
    Price to Book Ratio 2.97
    Return on Assets (%) 0.64
    Return on Capital (%) 1.34
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.66
    Total Assets 135.37
    Total Liabilities 135.37
    Total Equity 46.57
    Share Outstanding 0
    Price to Book Ratio 3.95
    Return on Assets (%) 10.13
    Return on Capital (%) 19.74
    Particulars MAR 2025 (Values in Cr)
    Net Income -3.24
    Cash from Operations -5.49
    Cash from Investing -5.16
    Cash from Financing 16.36
    Net change in Cash 5.81
    Free Cash Flow -0.06
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.13
    Cash from Operations 16.42
    Cash from Investing -13.32
    Cash from Financing -3.09
    Net change in Cash 0.00
    Free Cash Flow 29.51
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.18
    Cash from Operations 18.41
    Cash from Investing -15.59
    Cash from Financing -2.64
    Net change in Cash 0.17
    Free Cash Flow 31.94
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.14
    Cash from Operations 13.73
    Cash from Investing -16.81
    Cash from Financing 2.06
    Net change in Cash -1.01
    Free Cash Flow 30.89
    Particulars MAR 2021 (Values in Cr)
    Net Income 13.71
    Cash from Operations 13.53
    Cash from Investing -11.81
    Cash from Financing -2.05
    Net change in Cash -0.33
    Free Cash Flow 20.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.34 13.00 1.51 240.17 23.12 38.85
    BLISS GVS PHARMA LTD 513.65 41.29 4.56 5447.58 118.35 552.90
    CIPLA LTD. 1437.95 30.52 3.37 116164.12 1165.55 1672.20
    FERMENTA BIOTECH LTD. 456.50 20.14 3.30 1343.52 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2485.65 43.76 18.57 42108.41 2088.00 3221.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.34 21.92 4.03 240.17 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 534.65 23.96 4.17 1545.71 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8237.40 107.58 23.59 20593.50 7630.00 9850.00
    BLISS GVS PHARMA LTD 513.65 55.53 4.71 5447.58 118.35 552.90

    EVEREST ORGANICS LTD. shareholding pattern

    Holding
    40.37%
    59.6%
    0.02%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    EVEREST ORGANICS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    333.00 0.92 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 319.60
    • 26 Days 283.40
    • 10 Days 304.80
    • 50 Days 277.00
    • 12 Days 300.40
    • 100 Days 292.50
    • 20 Days 288.60
    • 200 Days 314.80
    331.33 PIVOT
    First Support 317.77 First Resistance 343.52 Second Support 305.58 Second Resistance 357.08 Third Support 292.02 Third Resistance 369.27
    RSI 77.32 ADX 31.07 MACD 17.03 Williams % R -14.96 Commodity Channel Index (CCI) 155.86
    Date 2026-07-15 Week 4040.00 Same Day 2428.00 Month 2990.00
    1 Year 0.82 3 Year 0.48
    Over 1 Month
    27.98% down
    Over 1 Year
    -0.01% down
    Over 3 Months
    33.50% down
    Over 3 Years
    37.81% down
    Over 6 Months
    -24.51% down
    Over 5 Years
    -1.05% down

    EVEREST ORGANICS LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    15 Sep 2022 0.5 Final 17 Sep 2022 Equity shares
    08 Sep 2021 1.0 Final 11 Sep 2021 Equity shares
    17 Feb 2021 0.5 Interim 18 Feb 2021 Equity shares
    01 Sep 2020 1.0 Final 03 Sep 2020 Equity shares
    03 Sep 2019 1.0 Final 05 Sep 2019 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Everest Organics Ltd?

    Answer Field

    Everest Organics Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 333.00 as on Jul 16 2026 03:29 PM.

    What is the Market Cap of Everest Organics Ltd Share?

    Answer Field

    The market cap of Everest Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 332.10 as on Jul 16 2026 03:29 PM.

    What is the 52 Week High and Low of Everest Organics Ltd?

    Answer Field

    The 52 Week High and Low of Everest Organics Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 536.40 and ₹ 197.00.

    What is 1 year return for Everest Organics Ltd?

    Answer Field

    The 1 year returns on the stock has been -0.01%.

    What is the P/E Ratio of Everest Organics Ltd Share?

    Answer Field

    As on Jul 16 2026 03:29 PM the price-to-earnings (PE) ratio for Everest Organics Ltd share is 59.34.

    What is the PB ratio of Everest Organics Ltd Share?

    Answer Field

    As on Jul 16 2026 03:29 PM, the price-to-book (PB) ratio for Everest Organics Ltd share is 79.69.

    How to Buy Everest Organics Ltd Share?

    Answer Field

    You can trade in Everest Organics Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Everest Organics Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Everest Organics Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Everest Organics Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |